Publications:

Predictive mutation signature of immunotherapy benefits in NSCLC based on machine learning algorithms.

Frontiers In Immunology

Liu, Zhichao Z; Lin, Guo G; Yan, Zeping Z; Li, Linduo L; Wu, Xingchen X; Shi, Jingrong J; He, Jianxing J; Zhao, Lei L; Liang, Hengrui H; Wang, Wei W

Publication Date: 2022

Variant appearance in text: ARID1A: 115G>C

PubMed Link: 36238300

Variant Present in the following documents:

• Table_1.xlsx, sheet 4

View BVdb publication page

EPHA5 mutation was associated with adverse outcome of atezolizumab treatment in late-stage non-small cell lung cancers.

Bmc Pulmonary Medicine

Li, Zhenxiang Z; Zhou, Qing Q; Wang, Qi Q; Wang, Haiyong H; Yue, Weiming W

Publication Date: 2022-09-19

Variant appearance in text: ARID1A: 115G>C

PubMed Link: 36123678

Variant Present in the following documents:

• 12890_2022_2161_MOESM2_ESM.xlsx, sheet 1

View BVdb publication page

Somatic mutation in synchronous primary adenocarcinomas of the left lung: a case report.

International Journal Of Clinical And Experimental Pathology

Yu, Xiaoli X; Sheng, Danli D; Jiang, Junchang J; Ren, Minpu M; Jin, Mei M; Xu, Songxiao S

Publication Date: 2015

Variant appearance in text: ARID1A: A39P

PubMed Link: 26339437

Variant Present in the following documents:

• Main text

View BVdb publication page